Archives

by in
Entry Author Date Location
One Giant Leap for Human Genomics Science and Business 09/26/12 Seattle
Foundation Medicine Grabs $42.5M For Cancer Genome Test 09/20/12 Boston
Illumina Steps Up Diagnostics Game, Acquires UK’s BlueGnome 09/19/12 San Diego
Complete Genomics Sold to BGI-Shenzhen for $117.6M 09/17/12 San Francisco
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
Illumina, Leaning on Amazon, Looks to Be Hub of Genomic Computing 07/24/12 San Diego
Scarcity of Samples Threatens Personalized Medicine 07/23/12 National
Xconomy Boston’s Top 20 Stories of Q2 2012: Editor’s Picks 07/03/12 Boston
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Ready or Not, Genomics is Coming to a Hospital Near You 06/11/12 National
Rubicon Genomics Launches New DNA Amplification Technology 06/05/12 Detroit
Complete Genomics Cuts Staff, Hires Banker for ‘Strategic Alternatives’ 06/05/12 San Francisco
NanoString Nabs Ex-Seattle Genetics Exec to Lead Diagnostic Push 05/29/12 Seattle
First Comes The $1,000 genome, Then Comes The $10,000 Analysis 05/08/12 Seattle
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work 05/02/12 San Francisco
The Affymetrix Alumni: Where Are They Now? 05/02/12 San Francisco
Taking Open Biology to the Next Level: Notes from the Sage Congress 04/27/12 National
Big Data, Big Biology, and the ‘Tipping Point’ in Quantified Health 04/26/12 San Diego
Illumina Opens Apple-Inspired App Store for DNA Software Developers 04/25/12 National
Illumina Stays Independent, Roche Walking Away 04/18/12 San Diego
San Diego Tech Roundup: Flud, Verve, and a “Swiss Cheese” Job Market 03/26/12 San Diego
OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics 03/21/12 Seattle
Five Reasons Illumina Should Fight Roche’s Insulting Low-Ball Bid 03/05/12 National
Oh, And One More Thing: A Wowser Moment in DNA Sequencing 02/21/12 National
Four Themes to Watch in Personalized Medicine 01/30/12 San Francisco
Roche Makes $5.7B Hostile Takeover Bid for Illumina 01/25/12 San Diego
Angry at the Genome 01/25/12 Boston
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes 01/09/12 Boston
PacBio CEO Hugh Martin Resigns, Being Replaced by Mike Hunkapiller 01/06/12 San Francisco
Page 3 of 11 « previous page · next page »